Study details
Enrolling now
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Navigator Medicines, Inc.
NCT IDNCT07384975ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Ages
18–70
Locations
10 sites in AZ, FL, KY +2
About this study
This Phase 2 study is focused on people with hidradenitis suppurativa.
Based on ClinicalTrials.gov records.
PhasePhase 2
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Change from baseline in AN count, Change from baseline in the number of draining tunnels, Proportion of participants achieving skin pain numeric rating scale (NRS) 30 response